Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ATRI's Cash to Debt is ranked higher than
95% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. ATRI: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ATRI' s 10-Year Cash to Debt Range
Min: 0.01  Med: 2.40 Max: No Debt
Current: No Debt
Equity to Asset 0.87
ATRI's Equity to Asset is ranked higher than
91% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. ATRI: 0.87 )
Ranked among companies with meaningful Equity to Asset only.
ATRI' s 10-Year Equity to Asset Range
Min: 0.54  Med: 0.79 Max: 0.88
Current: 0.87
0.54
0.88
Interest Coverage No Debt
ATRI's Interest Coverage is ranked higher than
92% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. ATRI: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ATRI' s 10-Year Interest Coverage Range
Min: 4  Med: 150.30 Max: 9999.99
Current: No Debt
4
9999.99
F-Score: 8
Z-Score: 24.15
M-Score: -2.28
WACC vs ROIC
11.48%
24.07%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 29.23
ATRI's Operating margin (%) is ranked higher than
94% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. ATRI: 29.23 )
Ranked among companies with meaningful Operating margin (%) only.
ATRI' s 10-Year Operating margin (%) Range
Min: 1.65  Med: 15.31 Max: 32.43
Current: 29.23
1.65
32.43
Net-margin (%) 19.82
ATRI's Net-margin (%) is ranked higher than
92% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. ATRI: 19.82 )
Ranked among companies with meaningful Net-margin (%) only.
ATRI' s 10-Year Net-margin (%) Range
Min: 4.35  Med: 16.54 Max: 56.77
Current: 19.82
4.35
56.77
ROE (%) 19.64
ATRI's ROE (%) is ranked higher than
89% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. ATRI: 19.64 )
Ranked among companies with meaningful ROE (%) only.
ATRI' s 10-Year ROE (%) Range
Min: 4.43  Med: 16.82 Max: 40.76
Current: 19.64
4.43
40.76
ROA (%) 17.11
ATRI's ROA (%) is ranked higher than
95% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. ATRI: 17.11 )
Ranked among companies with meaningful ROA (%) only.
ATRI' s 10-Year ROA (%) Range
Min: 3.63  Med: 13.84 Max: 32.36
Current: 17.11
3.63
32.36
ROC (Joel Greenblatt) (%) 41.43
ATRI's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. ATRI: 41.43 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ATRI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.06  Med: 26.80 Max: 257.02
Current: 41.43
3.06
257.02
Revenue Growth (3Y)(%) 7.10
ATRI's Revenue Growth (3Y)(%) is ranked higher than
62% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. ATRI: 7.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ATRI' s 10-Year Revenue Growth (3Y)(%) Range
Min: 5.4  Med: 7.70 Max: 56.2
Current: 7.1
5.4
56.2
EBITDA Growth (3Y)(%) 4.40
ATRI's EBITDA Growth (3Y)(%) is ranked lower than
55% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. ATRI: 4.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ATRI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -40.1  Med: 15.90 Max: 131.8
Current: 4.4
-40.1
131.8
EPS Growth (3Y)(%) 3.20
ATRI's EPS Growth (3Y)(%) is ranked lower than
54% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. ATRI: 3.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ATRI' s 10-Year EPS Growth (3Y)(%) Range
Min: 3.2  Med: 20.80 Max: 59.9
Current: 3.2
3.2
59.9
» ATRI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

ATRI Guru Trades in Q3 2014

Jim Simons 18,500 sh (+4.52%)
Chuck Royce 227,340 sh (+3.81%)
» More
Q4 2014

ATRI Guru Trades in Q4 2014

Jim Simons 18,800 sh (+1.62%)
Chuck Royce 188,385 sh (-17.14%)
Chuck Royce 188,385 sh (-17.14%)
» More
Q1 2015

ATRI Guru Trades in Q1 2015

Jim Simons 20,700 sh (+10.11%)
Chuck Royce 99,553 sh (-47.15%)
» More
Q2 2015

ATRI Guru Trades in Q2 2015

Jim Simons 24,800 sh (+19.81%)
Chuck Royce 53,900 sh (-45.86%)
Chuck Royce 74,116 sh (-25.55%)
» More
» Details

Insider Trades

Latest Guru Trades with ATRI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 25.61
ATRI's P/E(ttm) is ranked higher than
60% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.00 vs. ATRI: 25.61 )
Ranked among companies with meaningful P/E(ttm) only.
ATRI' s 10-Year P/E(ttm) Range
Min: 8.12  Med: 16.31 Max: 27.15
Current: 25.61
8.12
27.15
Forward P/E 26.18
ATRI's Forward P/E is ranked lower than
69% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.74 vs. ATRI: 26.18 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 26.10
ATRI's PE(NRI) is ranked higher than
58% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.40 vs. ATRI: 26.10 )
Ranked among companies with meaningful PE(NRI) only.
ATRI' s 10-Year PE(NRI) Range
Min: 8.12  Med: 16.34 Max: 27.15
Current: 26.1
8.12
27.15
P/B 5.09
ATRI's P/B is ranked lower than
75% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. ATRI: 5.09 )
Ranked among companies with meaningful P/B only.
ATRI' s 10-Year P/B Range
Min: 1.23  Med: 2.65 Max: 5.42
Current: 5.09
1.23
5.42
P/S 5.07
ATRI's P/S is ranked lower than
71% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. ATRI: 5.07 )
Ranked among companies with meaningful P/S only.
ATRI' s 10-Year P/S Range
Min: 1.2  Med: 2.83 Max: 5.38
Current: 5.07
1.2
5.38
PFCF 32.55
ATRI's PFCF is ranked lower than
58% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.56 vs. ATRI: 32.55 )
Ranked among companies with meaningful PFCF only.
ATRI' s 10-Year PFCF Range
Min: 7.41  Med: 18.86 Max: 429.32
Current: 32.55
7.41
429.32
POCF 21.66
ATRI's POCF is ranked lower than
62% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.43 vs. ATRI: 21.66 )
Ranked among companies with meaningful POCF only.
ATRI' s 10-Year POCF Range
Min: 5.98  Med: 11.91 Max: 23.49
Current: 21.66
5.98
23.49
EV-to-EBIT 16.27
ATRI's EV-to-EBIT is ranked higher than
66% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. ATRI: 16.27 )
Ranked among companies with meaningful EV-to-EBIT only.
ATRI' s 10-Year EV-to-EBIT Range
Min: 4.6  Med: 11.30 Max: 17.5
Current: 16.27
4.6
17.5
PEG 3.35
ATRI's PEG is ranked lower than
59% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. ATRI: 3.35 )
Ranked among companies with meaningful PEG only.
ATRI' s 10-Year PEG Range
Min: 0.2  Med: 1.09 Max: 6.3
Current: 3.35
0.2
6.3
Shiller P/E 29.53
ATRI's Shiller P/E is ranked higher than
50% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.14 vs. ATRI: 29.53 )
Ranked among companies with meaningful Shiller P/E only.
ATRI' s 10-Year Shiller P/E Range
Min: 11.49  Med: 22.10 Max: 31.36
Current: 29.53
11.49
31.36
Current Ratio 8.23
ATRI's Current Ratio is ranked higher than
93% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. ATRI: 8.23 )
Ranked among companies with meaningful Current Ratio only.
ATRI' s 10-Year Current Ratio Range
Min: 1.33  Med: 4.28 Max: 9.73
Current: 8.23
1.33
9.73
Quick Ratio 5.09
ATRI's Quick Ratio is ranked higher than
89% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. ATRI: 5.09 )
Ranked among companies with meaningful Quick Ratio only.
ATRI' s 10-Year Quick Ratio Range
Min: 1.16  Med: 2.18 Max: 6.84
Current: 5.09
1.16
6.84
Days Inventory 135.48
ATRI's Days Inventory is ranked lower than
53% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. ATRI: 135.48 )
Ranked among companies with meaningful Days Inventory only.
ATRI' s 10-Year Days Inventory Range
Min: 74.75  Med: 124.02 Max: 140.27
Current: 135.48
74.75
140.27
Days Sales Outstanding 53.38
ATRI's Days Sales Outstanding is ranked higher than
66% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. ATRI: 53.38 )
Ranked among companies with meaningful Days Sales Outstanding only.
ATRI' s 10-Year Days Sales Outstanding Range
Min: 34.8  Med: 41.65 Max: 433.63
Current: 53.38
34.8
433.63

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.79
ATRI's Dividend Yield is ranked lower than
76% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. ATRI: 0.79 )
Ranked among companies with meaningful Dividend Yield only.
ATRI' s 10-Year Dividend Yield Range
Min: 0.67  Med: 0.90 Max: 1.74
Current: 0.79
0.67
1.74
Dividend Payout 0.20
ATRI's Dividend Payout is ranked higher than
83% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.34 vs. ATRI: 0.20 )
Ranked among companies with meaningful Dividend Payout only.
ATRI' s 10-Year Dividend Payout Range
Min: 0.04  Med: 0.16 Max: 0.59
Current: 0.2
0.04
0.59
Dividend growth (3y) 15.20
ATRI's Dividend growth (3y) is ranked higher than
65% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. ATRI: 15.20 )
Ranked among companies with meaningful Dividend growth (3y) only.
ATRI' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 15.20 Max: 45.5
Current: 15.2
0
45.5
Yield on cost (5-Year) 1.65
ATRI's Yield on cost (5-Year) is ranked higher than
51% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.61 vs. ATRI: 1.65 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ATRI' s 10-Year Yield on cost (5-Year) Range
Min: 1.4  Med: 1.88 Max: 3.64
Current: 1.65
1.4
3.64
Share Buyback Rate 0.90
ATRI's Share Buyback Rate is ranked higher than
86% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. ATRI: 0.90 )
Ranked among companies with meaningful Share Buyback Rate only.
ATRI' s 10-Year Share Buyback Rate Range
Min: 12.9  Med: 0.20 Max: -2.4
Current: 0.9

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 14.00
ATRI's Price/Net Current Asset Value is ranked lower than
72% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.89 vs. ATRI: 14.00 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ATRI' s 10-Year Price/Net Current Asset Value Range
Min: 1.58  Med: 9.21 Max: 371.88
Current: 14
1.58
371.88
Price/Tangible Book 5.59
ATRI's Price/Tangible Book is ranked lower than
62% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. ATRI: 5.59 )
Ranked among companies with meaningful Price/Tangible Book only.
ATRI' s 10-Year Price/Tangible Book Range
Min: 0.54  Med: 2.39 Max: 5.72
Current: 5.59
0.54
5.72
Price/Projected FCF 1.90
ATRI's Price/Projected FCF is ranked lower than
59% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. ATRI: 1.90 )
Ranked among companies with meaningful Price/Projected FCF only.
ATRI' s 10-Year Price/Projected FCF Range
Min: 0.74  Med: 1.55 Max: 13.74
Current: 1.9
0.74
13.74
Price/Median PS Value 1.79
ATRI's Price/Median PS Value is ranked lower than
83% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. ATRI: 1.79 )
Ranked among companies with meaningful Price/Median PS Value only.
ATRI' s 10-Year Price/Median PS Value Range
Min: 0.18  Med: 0.65 Max: 1.83
Current: 1.79
0.18
1.83
Price/Peter Lynch Fair Value 4.18
ATRI's Price/Peter Lynch Fair Value is ranked lower than
94% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. ATRI: 4.18 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ATRI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.37  Med: 0.81 Max: 4.28
Current: 4.18
0.37
4.28
Price/Graham Number 2.47
ATRI's Price/Graham Number is ranked higher than
50% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. ATRI: 2.47 )
Ranked among companies with meaningful Price/Graham Number only.
ATRI' s 10-Year Price/Graham Number Range
Min: 0.47  Med: 1.28 Max: 2.53
Current: 2.47
0.47
2.53
Earnings Yield (Greenblatt) (%) 6.11
ATRI's Earnings Yield (Greenblatt) (%) is ranked higher than
78% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. ATRI: 6.11 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ATRI' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 5.7  Med: 8.85 Max: 21.6
Current: 6.11
5.7
21.6
Forward Rate of Return (Yacktman) (%) 8.93
ATRI's Forward Rate of Return (Yacktman) (%) is ranked lower than
57% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.13 vs. ATRI: 8.93 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ATRI' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -16.8  Med: 17.00 Max: 73.9
Current: 8.93
-16.8
73.9

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Atrion Corp is incorporated in Delaware. The Company and its subsidiaries develop and manufacture products, mainly for medical applications. Its medical products include fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include proprietary valves that promote infection control and needle safety. It has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. It also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications including anesthesia and oncology. Its cardiovascular products include MPS2 Myocardial Protection System, or MPS2, a proprietary technology that delivers essential fluids and medications to the heart during open-heart surgery. The MPS2 integrates key functions relating to the delivery of solutions to the heart, such as varying the rate and ratio of oxygenated blood, crystalloid, potassium and other additives, and controlling temperature, pressure and other variables to allow simpler, more flexible management of this process, indicating improved patient outcomes. The MPS2 is the only device used in open-heart surgery that allows for the mixing of drugs into the bloodstream without diluting the blood. The MPS2 employs pump, temperature control and microprocessor technologies and includes a line of disposable products. It also develop and manufacture other cardiovascular products such as cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels in minimally invasive surgical procedures; inflation devices for balloon catheter dilation, stent deployment and fluid dispensing; as well as products used in heart bypass surgery to make a precision opening in the heart for attachment of the bypass vessels. The Company is a manufacturer of contact lens disinfection cases. It also manufacture a proprietary line of balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. Nasolacrimal duct obstruction can cause a condition called epiphora, or chronic tearing. People affected by this condition experience excessive and uncontrollable tearing and often encounter infection as a result of nasolacrimal blockage. In addition, it manufactures and sells a line of products designed for safe needle and scalpel blade containment. It is also the manufacturer of inflation systems and valves used in marine and aviation safety products. It manufactures inflation systems and valves for products such as life vests, life rafts, inflatable boats, survival equipment, and other inflatable structures. It also produce one-way and two-way pressure relief valves for use on electronics cases, munitions cases, pressure vessels,
» More Articles for ATRI

Headlines

Articles On GuruFocus.com
Atrion Corporation Increases Quarterly Cash Dividend by 20% Aug 04 2015 
Atrion Reports Second Quarter Results Aug 04 2015 
Atrion Corporation Declares Quarterly Cash Dividend Nov 14 2014 
3 Cheap Health Care Dividend Stocks with Huge Potential to Grow Dividends Oct 02 2013 
Billionaires Hold Three Undervalued, Predictable Stocks with Yield Sep 16 2013 
26 Stocks Raised Dividends Over the Past Week Aug 18 2013 
My 4 Favorite Dividend Contenders with Highest Dividend Growth Potential May 24 2013 
Atrion Corporation: Track Record of Delivery Dec 03 2012 
comment on ATRI Oct 06 2012 
How to Look Beyond Dividend Increases Aug 27 2012 

More From Other Websites
Atrion Corp. Q2 Earnings, 2015 Aug 25 2015
ATRION CORP Financials Aug 12 2015
10-Q for Atrion Corp. Aug 06 2015
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition Aug 04 2015
Atrion Reports Second Quarter Results Aug 04 2015
Atrion Corporation Increases Quarterly Cash Dividend by 20% Aug 04 2015
ATRION CORP Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Submission of Matters to a... May 22 2015
Atrion Corporation Declares Quarterly Cash Dividend May 21 2015
Atrion posts 1Q profit May 06 2015
Atrion posts 1Q profit May 06 2015
ATRION CORP Files SEC form 8-K, Financial Statements and Exhibits May 06 2015
Atrion Reports First Quarter Results May 06 2015
ATRION CORP Files SEC form 10-K, Annual Report Mar 13 2015
Atrion Corporation Declares Quarterly Cash Dividend Mar 03 2015
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition Feb 23 2015
Atrion Reports Fourth Quarter and Full Year 2014 Results Feb 23 2015
Atrion Corporation Declares Quarterly Cash Dividend Nov 14 2014
ATRION CORP Files SEC form 8-K, Results of Operations and Financial Condition Oct 31 2014
Atrion Reports Third Quarter Results Oct 31 2014
Atrion Corporation Increases Quarterly Cash Dividend by 17% Sep 03 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK